Cerity Partners’s Novanta NOVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.04M Sell
12,550
-7,102
-36% -$1.03M ﹤0.01% 1584
2026
Q1
$2.32M Buy
19,652
+6,099
+45% +$800K ﹤0.01% 1404
2025
Q4
$1.61M Buy
+13,553
New +$1.54M ﹤0.01% 1465
2024
Q4
– Sell
-1,160
Closed -$208K – 2540
2024
Q3
$208K Buy
+1,160
New +$202K ﹤0.01% 2302

Other funds holding NOVT

Cerity Partners's NOVT Position: Q2 2026 in Review

Cerity Partners reduced its Novanta (NOVT) stake by 36% in Q2 2026, selling an estimated $1.03M and leaving 12,550 shares worth $2.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1584.

Cerity Partners first reported a position in NOVT in Q3 2024 and has held it in 4 quarters since. The position peaked at $2.32M in Q1 2026. 391 funds tracked by Wall St. Rank hold NOVT as of Q2 2026.

  • Cerity Partners held 12,550 shares of Novanta worth $2.04M as of Q2 2026.
  • Cerity Partners sold 7,102 Novanta shares in Q2 2026, an estimated $1.03M.
  • Novanta made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #1584 holding.
  • Cerity Partners first reported a position in Novanta in Q3 2024 and has held it in 4 quarters since.
  • Cerity Partners's Novanta position peaked at $2.32M in Q1 2026.
  • 391 funds tracked by Wall St. Rank held Novanta as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.